Metastatic carcinoid tumors and the malignant carcinoid syndrome.
Kvols
L K
LK
Mayo Clinic, Rochester, Minnesota 55905.
D014408:Biomarkers, Tumor / Q000032:analysis; D002275:Carcinoid Heart Disease / Q000628:therapy; D002276:Carcinoid Tumor / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D002945:Cisplatin / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003533:Cyproheptadine / Q000627:therapeutic use; D004452:Echocardiography; D005047:Etoposide / Q000627:therapeutic use; D006801:Humans; D007370:Interferon Type I / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008303:Malignant Carcinoid Syndrome / Q000175:diagnosis / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis; D017481:Receptors, Somatostatin / Q000032:analysis; D011994:Recombinant Proteins
D014408:Biomarkers, Tumor; D007370:Interferon Type I; D017481:Receptors, Somatostatin; D011994:Recombinant Proteins; D003533:Cyproheptadine; D005047:Etoposide; D002945:Cisplatin